Related Experiment Video
Updated: Aug 13, 2025
08:01
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
7.4K
Functionalized PAMAM constructed nanosystems for biomacromolecule delivery.
Ka Hong Wong1, Zhaopei Guo1, Man-Kay Law2
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China. mwchen@um.edu.mo.
Biomaterials Science
|January 24, 2023
Summary
Polyamidoamine (PAMAM) dendrimers offer efficient delivery of therapeutic macromolecules like genes and proteins. Their versatile functionalization and assembly enable customized drug delivery systems with minimal side effects.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Polyamidoamines (PAMAMs) are monodisperse dendrimers with controllable structures.
- PAMAMs can encapsulate and deliver therapeutic macromolecules such as genes and proteins.
- Functionalization allows for tailored PAMAM carriers for specific therapeutic applications.
Purpose of the Study:
- To comprehensively review PAMAM applications in biomacromolecule delivery.
- To discuss synthesis strategies for functionalized PAMAM carriers.
- To explore the development of PAMAM-based drug delivery systems.
Main Methods:
- Review of literature on PAMAM synthesis and functionalization.
- Analysis of self-assembled, cross-linked, and hybrid PAMAM systems.
- Evaluation of PAMAMs as carriers for gene and protein delivery.
Main Results:
- PAMAMs can be easily modified via core or surface functionalization.
- Various PAMAM architectures (self-assembled, cross-linked, hybrid) are developed for drug delivery.
- PAMAMs demonstrate high efficiency and reduced side effects in biomacromolecule delivery.
Conclusions:
- PAMAM dendrimers are promising for advanced biomacromolecule therapy.
- Functionalization and assembly strategies are key to developing effective PAMAM delivery systems.
- Further research into PAMAM applications can advance drug delivery technologies.
